Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY

v3.21.2
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY - USD ($)
Preferred Stock
Common Stock
Private Placement
Common Stock
Registered Direct Offering
Common Stock
Additional Paid-In Capital
Private Placement
Additional Paid-In Capital
Registered Direct Offering
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Private Placement
Registered Direct Offering
Total
Balance at Dec. 31, 2019 $ 41     $ 40,778     $ 106,689,065 $ 139,465 $ (100,246,894)     $ 6,622,455
Balance (in shares) at Dec. 31, 2019 4,092     4,077,775                
Stock-Based Compensation             530,704         530,704
Issuance of Common Stock in Offerings, Net of Offering Costs       $ 5,000     4,496,313         4,501,313
Issuance of Common Stock in Offerings, Net of Offering Costs (in shares)       500,000                
Issuance of Common Stock from Restricted Stock Award Grants       $ 490     (490)          
Issuance of Common Stock from Restricted Stock Award Grants (in shares)       49,000                
Foreign Currency Translation Adjustment               (16,944)       (16,944)
Net Loss                 (5,676,175)     (5,676,175)
Balance at Sep. 30, 2020 $ 41     $ 46,268     111,715,592 122,521 (105,923,069)     5,961,353
Balance (in shares) at Sep. 30, 2020 4,092     4,626,755                
Balance at Jun. 30, 2020 $ 41     $ 46,268     111,527,859 139,631 (103,916,195)     7,797,604
Balance (in shares) at Jun. 30, 2020 4,092     4,626,755                
Stock-Based Compensation             187,733         187,733
Foreign Currency Translation Adjustment               (17,110)       (17,110)
Net Loss                 (2,006,874)     (2,006,874)
Balance at Sep. 30, 2020 $ 41     $ 46,268     111,715,592 122,521 (105,923,069)     5,961,353
Balance (in shares) at Sep. 30, 2020 4,092     4,626,755                
Balance at Dec. 31, 2020 $ 41     $ 55,564     115,283,572 (802) (108,338,834)     6,999,541
Balance (in shares) at Dec. 31, 2020 4,138     5,556,394                
Stock-Based Compensation             629,306         629,306
Issuance of Common Stock in Offerings, Net of Offering Costs   $ 15,311 $ 46,689   $ 7,973,550 $ 9,709,659       $ 7,988,861 $ 9,756,348  
Conversion of Series C Preferred Stock into Common Stock $ (41)     $ 8,525     (8,484)         8,525
Conversion of Series C Preferred Stock into Common Stock (in shares) (4,092)     852,500                
Issuance of Common Stock in Offerings, Net of Offering Costs (in shares)   1,531,101 4,668,844                  
Issuance of Common Stock from Warrants, Net       $ 104     49,897         50,001
Issuance of Common Stock from Warrants, Net (in shares)       10,417                
Foreign Currency Translation Adjustment               (59,068)       (59,068)
Net Loss                 (8,016,943)     (8,016,943)
Balance at Sep. 30, 2021       $ 126,193     133,637,500 (59,870) (116,355,777)     17,348,046
Balance (in shares) at Sep. 30, 2021 46     12,619,256                
Balance at Jun. 30, 2021 $ 41     $ 70,979     123,786,856 (15,136) (113,388,953)     10,453,787
Balance (in shares) at Jun. 30, 2021 4,138     7,097,912                
Stock-Based Compensation             149,469         149,469
Issuance of Common Stock in Offerings, Net of Offering Costs     $ 46,689     $ 9,709,659         $ 9,756,348  
Conversion of Series C Preferred Stock into Common Stock $ (41)     $ 8,525     (8,484)          
Conversion of Series C Preferred Stock into Common Stock (in shares) (4,092)     852,500                
Issuance of Common Stock in Offerings, Net of Offering Costs (in shares)     4,668,844                  
Foreign Currency Translation Adjustment               (44,734)       (44,734)
Net Loss                 (2,966,824)     (2,966,824)
Balance at Sep. 30, 2021       $ 126,193     $ 133,637,500 $ (59,870) $ (116,355,777)     $ 17,348,046
Balance (in shares) at Sep. 30, 2021 46     12,619,256